Society of Interventional Oncology
-
Register
- Non-member - $30
- Member - $15
Already registered?
Log in now.
This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!
| MODERATOR | David Breen, MD, MRCP, FRCR |
| MODERATOR | Naomi Balzer Haas, MD |
| T1B Lesions: IR Approaches | Tim McClure, MD |
| T1B Lesions: Surgeon Approaches | John Leppert, MD |
| Immunotherapy for Prostate and RCC | Naomi Balzer Haas, MD |
| IR for Localized & Advanced Prostate Cancer | David Woodrum, MD, PhD |
| Addressing Oligometastatic Disease in Prostate and RCC | Nick Anil Kurup, MD |
| 957496 Preclinical Validation of Synergistic Local Combination of Radiation and PD-L1 Immunotherapy Using Radiation Responsive Nanocarriers for the Treatment of Prostate Cancer | David Woodrum, MD, PhD |
| Q&A | All Faculty |
Key:
Complete
Next
Failed
Available
Locked